Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal dominant Charcot-Marie-Tooth disease type 2B (CMT2B) is a severe form of axonal Charcot-Marie-Tooth disease, a peripheral sensorimotor neuropathy. CMT2B onset, in the 2nd or 3rd decade, is characterized by ulcerations and infections of feet. Symmetric and distal weakness develops mostly in the legs together with a severe symmetric distal sensory loss, tendon reflexes are only reduced at ankles and foot deformities, including pes cavus or planus and hammer toes, appear in childhood.
Features include always present findings: Decreased motor nerve conduction velocity, Steppage gait, Fasciculations, and Nerve damage affecting sensation and movement (sensorimotor neuropathy) and others. 27 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Steppage gait, Fasciculations, Nerve damage affecting sensation and movement (sensorimotor neuropathy) |
Muscles | 6 | Distal muscle weakness, Fasciculations, Foot dorsiflexor weakness |
Arms and legs | 6 | Foot dorsiflexor weakness, Autoamputation of foot, Foot osteomyelitis |
Bones and joints | 1 | Foot osteomyelitis |
RAB7A function has not been fully characterized.
Charcot-Marie-Tooth disease type 2B is associated with mutations in the RAB7A gene on chromosome 3.
Genetic testing for RAB7A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 11 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Charcot-Marie-Tooth disease type 2B.
4 publications have been identified in PubMed for Charcot-Marie-Tooth disease type 2B. Research spans Case Report / Case Series (25%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (25%).
Kodal LS (2025). [PMID: 41310508](https://pubmed.ncbi.nlm.nih.gov/41310508/). *BMC neurology*. [Case Report / Case Series]
Kang S (2025). [PMID: 39663592](https://pubmed.ncbi.nlm.nih.gov/39663592/). *Autophagy*. [Basic Science / Preclinical]
Girolimetti G (2025). [PMID: 40774391](https://pubmed.ncbi.nlm.nih.gov/40774391/). *Neurobiology of disease*. [Epidemiology / Natural History]
Wilhelm SDP (2024). [PMID: 39352000](https://pubmed.ncbi.nlm.nih.gov/39352000/). *IUBMB life*. [Gene Therapy / Novel Therapeutics]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease type 2B